Normal view MARC view ISBD view

Ma, Jianguo

Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance. [electronic resource] - Biochemical pharmacology Apr 2002 - 1219-28 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.

ISSN: 0006-2952

Standard No.: 10.1016/s0006-2952(02)00876-6 doi

Subjects--Topical Terms:
Adaptor Proteins, Signal Transducing
Adenosine Triphosphatases--biosynthesis
Antineoplastic Agents, Alkylating--pharmacology
Antineoplastic Agents, Phytogenic--pharmacology
Carrier Proteins
Cell Cycle--drug effects
Cyclin-Dependent Kinase Inhibitor p21
Cyclins--biosynthesis
DNA Repair Enzymes
DNA-Binding Proteins--biosynthesis
Dacarbazine--analogs & derivatives
Doxorubicin--pharmacology
Drug Interactions
Drug Resistance, Multiple--physiology
Drug Screening Assays, Antitumor
Glioma--pathology
Guanine--analogs & derivatives
Humans
Mismatch Repair Endonuclease PMS2
MutL Protein Homolog 1
Neoplasm Proteins--biosynthesis
Nuclear Proteins
O(6)-Methylguanine-DNA Methyltransferase--metabolism
Paclitaxel--pharmacology
Phenotype
Proto-Oncogene Proteins c-bcl-2--metabolism
Temozolomide
Tumor Cells, Cultured
Tumor Suppressor Protein p53--biosynthesis